Show
10
20
30
40
results per page
CATCO Scale-Up COVID‑19 Supplement – Canadian Treatments for COVID-19: SOLIDARITY
Murthy, Srinivas |
University of British Columbia | Operating Grant | $3,500,000
CIHR British Columbia 2021
Read More
COVID-19 Variant Network – Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals
Langlois, Marc-Andre |
University of Ottawa | Operating Grant | $100,000
CIHR Ontario 2021
Read More
Mitigating suicide risk during the COVID‑19 pandemic via telehealth using an intensive single session of “Brief Skills for Safer Living”
Rizvi, Sakina |
Unity Health Toronto | Operating Grant | $193,000
CIHR Ontario 2020
Read More
COVID-19 Variant Supplement – SARS-CoV-2 immunization strategies to enhance protective immunity with reduced risk of antibody-dependent enhancement (ADE)
Archambault, Denis |
Université du Québec à Montréal | Operating Grant | $50,000
CIHR Quebec 2021
Read More
Responding to dual public health crises in the Emergency Department: Advancing patient-centered care for people who use opioids during COVID-19
Hyshka, Elaine |
Royal Alexandra Hospital | Operating Grant | $196,366
CIHR Alberta 2020
Read More
From idea to reality: COVID‑19 Vaccination for Children and Youth
Maguire, Jonathon L |
Unity Health Toronto | Operating Grant | $496,871
CIHR Ontario 2021
Read More
Predicting perceived and unmet mental health needs in the populations
Wang, JianLi |
Dalhousie University | Project Grant | $137,700
CIHR Nova Scotia 2021
Read More
COVID-19 Variant Supplement – Optimizing polar, small inhibitors of a viral cysteine protease to identify a lead for an oral COVID‑19 treatment
Lemieux, Joanne M |
University of Alberta | Operating Grant | $50,000
CIHR Alberta 2021
Read More
Immunity Passports for COVID-19: Scientific, Ethical, Policy and Design Implications
Wilson, Kumanan |
Bruyère Research Institute | Operating Grant | $236,858
CIHR Ontario 2020
Read More
Determine how the interaction between SARS-CoV-2 spike protein and angiotensin-converting enzyme 2 (ACE2) affect viral spread and the severity of COVID‑19 outcomes.
Su, Ruey-Chyi |
University of Manitoba | Operating Grant | $431,000
CIHR Manitoba 2021
Read More